VitaLonga

Desk

News archive

Every story stays here. Filter by topic, search older headlines, and save favorites to your member record. Educational notes only — not medical advice.

Saved (sign in)

465 stories

Yonsei University / European Society of Cardiology / New England Journal of Medicine · 27 Sept 2026 · Supplements / medicine

In 1,803 people with atrial fibrillation at intermediate stroke risk, a direct oral anticoagulant cut the combined event rate by 69% at 24 months

Study (open-label randomized trial). Boyoung Joung of Yonsei University and colleagues presented SINGLE-AF at ESC Congress 2026 and in the New England Journal of Medicine (2026; 395(12):1155; doi 10.1056/NEJMoa2607978; ScienceDaily 27 September 2026). At 18 centers in South Korea, 1,803 people with atrial fibrillation and an intermediate stroke score (CHA2DS2-VASc of 1 in men or 2 in women) were assigned to a direct oral anticoagulant (apixaban 5 mg twice daily or rivaroxaban 20 mg once daily) or to no anticoagulation. At 24 months the combined endpoint of stroke, systemic embolism, major bleeding, and cardiovascular death occurred in 0.5% on anticoagulation versus 1.5% without it (hazard ratio 0.31; 95% CI 0.10 to 0.94; p=0.028). Ischemic stroke was 0.1% versus 1.1%. Major bleeding was 0.3% versus 0.5%. Absolute event counts are small. The trial was open-label. Educational notes. Starting or stopping anticoagulation is a clinician decision. This is not a reason to begin a prescription from a headline.

Read at Yonsei University / European Society of Cardiology / New England Journal of Medicine →♡ Save

  • Women
  • Men
  • Cardiovascular / lipids
  • study
  • off-label-context

ScienceDaily · 21 Sept 2026 · Supplements / medicine

Millions take calcium and vitamin D for bone health. A major review finds little benefit

A sweeping review of more than 153,000 adults found that calcium and vitamin D supplements, alone or together, do little to prevent fractures or falls in most older people. Researchers say the findings challenge routine supplementation for prevention and point instead toward strategies such as balance and resistance exercise.

Read at ScienceDaily →♡ Save

  • news
  • fitness

ScienceDaily · 20 Sept 2026 · Nutrition

8 common food additives linked to high blood pressure and heart disease

Common preservatives hiding in processed foods may carry unexpected heart risks, with heavy consumption linked to substantially higher rates of high blood pressure and cardiovascular disease. Researchers identified eight widely used preservatives associated with hypertension, although the observational study cannot prove they were directly responsible.

Read at ScienceDaily →♡ Save

  • Cardiovascular / lipids
  • news
  • study

ScienceDaily · 13 Sept 2026 · Aging

Scientists find a new layer of Alzheimer’s hidden in the genome

Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. The discovery reveals a previously underexplored layer of the disease that could open new paths for understanding and eventually treating Alzheimer’s.

Read at ScienceDaily →♡ Save

  • Cognitive / dementia research
  • cognition

WHO · 25 May 2025 · Exercise

African Union and World Health Organization renew strategic partnership to drive impact and strengthen health systems in Africa

The World Health Organization (WHO) and the African Union (AU) Commission renewed their longstanding strategic partnership today with the signing of an updated Memorandum of Understanding (MoU) on the sidelines of the 78th World Health Assembly in Geneva. This renewed agreement reaffirms the joint commitment to advancing health security, universal health coverage, and sustainable development across the African contin

Read at WHO →♡ Save

  • muscle

WHO · 25 Jan 2026 · Research

WHO statement on notification of withdrawal of the United States

WHO regrets the United States’ notification of withdrawal from WHO – a decision that makes both the United States and the world less safe. The notification of withdrawal raises issues that will be considered by the WHO Executive Board at its regular meeting starting on 2 February and by the World Health Assembly at its annual meeting in May 2026.

Read at WHO →♡ Save

  • news

ScienceDaily · 20 Sept 2026 · Nutrition

Hidden gut defect that may explain why IBD keeps coming back

Researchers have uncovered a hidden molecular warning sign of inflammatory bowel disease (IBD) that can linger even when patients feel well and appear to be in remission. By studying around 900 human gut biopsies and patient-derived mini-intestines, the team found that intestinal cells can remain unusually primed to die, creating a “smoldering” defect that may help drive future flare-ups.

Read at ScienceDaily →♡ Save

  • news
  • gut
  • inflammation
  • study

ScienceDaily · 13 Sept 2026 · Nutrition

A hidden compound in healthy foods may worsen IBD

A natural compound found in foods such as spinach, almonds, and sweet potatoes may aggravate gut inflammation in people with Crohn’s disease and ulcerative colitis because their intestines appear to handle it differently. Researchers say the finding could open the door to lower-oxalate diets or microbiome treatments tailored specifically to people with IBD.

Read at ScienceDaily →♡ Save

  • news
  • gut
  • inflammation

ScienceDaily · 13 Sept 2026 · Supplements / medicine

Ozempic and Wegovy may raise hair loss risk in some men

GLP-1 drugs such as Ozempic, Wegovy, and Zepbound may increase hair-loss risk by 7% in men who are already genetically susceptible to male-pattern baldness. The findings suggest thinning hair may not be caused only by rapid weight loss and could also reflect a biological link between GLP-1 activity and hair follicles. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.

Read at ScienceDaily →♡ Save

  • Men
  • news
  • glp1
  • off-label-context
  • aging
  • nutrition

VitaLonga is an educational longevity resource, not a pharmacy, clinic, or doctor. Content is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease (DSHEA). Supplements can interact with medications and are not appropriate in every pregnancy or health condition. Consult a licensed clinician, especially if you take medications, are pregnant or nursing, or have a diagnosed condition.